{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:06:05Z","timestamp":1792641965283,"version":"4.5.0"},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2007,8,20]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The American College of Surgeons Oncology Group trial Z0011 was a prospective, randomized, multicenter trial comparing overall survival between patients with positive sentinel lymph nodes (SLNs) who did and did not undergo axillary lymph node dissection (ALND). The current study compares complications associated with SLN dissection (SLND) plus ALND, versus SLND alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>From May 1999 to December 2004, 891 patients were randomly assigned to SLND + ALND (n = 445) or SLND alone (n = 446). Information on wound infection, axillary seroma, paresthesia, brachial plexus injury (BPI), and lymphedema was available for 821 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Adverse surgical effects were reported in 70% (278 of 399) of patients after SLND + ALND and 25% (103 of 411) after SLND alone (P \u2264 .001). Patients in the SLND + ALND group had more wound infections (P \u2264 .0016), seromas (P \u2264 .0001), and paresthesias (P \u2264 .0001) than those in the SLND-alone group. At 1 year, lymphedema was reported subjectively by 13% (37 of 288) of patients after SLND + ALND and 2% (six of 268) after SLND alone (P \u2264 .0001). The difference between the two groups' lymphedema, assessed by arm measurements at 30 days (P = .36), 6 months (P = .22), and 1 year (P = .078), although close to the cutoff for significance at 1 year, was not significant. BPIs occurred in less than 1% of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In trial Z0011, the use of SLND + ALND resulted in more wound infections, axillary seromas, and paresthesias than SLND alone. Lymphedema was more common after SLND + ALND but was significantly different only by subjective report. The use of SLND alone resulted in fewer complications.<\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2006.07.4062","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T00:40:56Z","timestamp":1178584856000},"page":"3657-3663","source":"Crossref","is-referenced-by-count":791,"title":["Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011"],"prefix":"10.1200","volume":"25","author":[{"given":"Anthony","family":"Lucci","sequence":"first","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Mackie","family":"McCall","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Beitsch","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Whitworth","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reintgen","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Blumencranz","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marilyn","family":"Leitch","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukumal","family":"Saha","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando E.","family":"Giuliano","sequence":"additional","affiliation":[{"name":"From the Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston; Dallas Surgical Group; The University of Texas Southwestern, Dallas, TX; American College of Surgeons Oncology Group, Durham, NC; Nashville Breast Center, Nashville, TN; Lakeland Cancer Center, Lakeland; Morton Plant Mease Healthcare, Clearwater, FL; McClaren Regional Medical Center, Flint, MI; and John Wayne Cancer Institute, Santa Monica, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198503143121102"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Anonymous: Cancer research campaign (King's\/Cambridge) trial for early breast cancer: A detailed update at the tenth year\u2014Cancer Res Campaign Working Party. Lancet 2:55,1980-60,","DOI":"10.1016\/S0140-6736(80)92939-6"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0109-1"},{"key":"R4","unstructured":"White RE, Vezeridis MP, Konstadoulakis M, et al: Therapeutic options and results for the management of minimally invasive carcinoma of the breast: Influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 183:575,1996-582,"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199409000-00015"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540220042028"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00848-0"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Langer S, Guenther JM, Haigh PI, et al: Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg 70:881,2004-885,","DOI":"10.1177\/000313480407001011"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.228"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, et al: Post-operative arm morbidity and quality of life: Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279,2005-293,","DOI":"10.1007\/s10549-005-9025-7"},{"key":"R11","unstructured":"Fleming ID, Cooper JS, Henson DE: AJCC Cancer Staging Manual (ed 5) . Philadelphia, PA, Lippincott-Raven, 1997"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-003-7193-3"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00843.x"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4741.2003.09505.x"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00067-3"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023330206021"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.05.013"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Karges JR, Mark BE, Stikeleather SJ, et al: Concurrent validity of upper-extremity volume estimates: Comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 83:134,2003-145,","DOI":"10.1093\/ptj\/83.2.134"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2001.26822"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2005.11.008"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1007\/BF02573889"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1007\/BF02574481"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20406"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Querci della Rovere G, Ahmad I, Singh P, et al: An audit of the incidence of arm lymphoedema after prophylactic level I\/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl 85:158,2003-161,","DOI":"10.1308\/003588403321661299"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011001)92:7<1783::AID-CNCR1694>3.0.CO;2-G"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000129358.80798.62"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-5991-z"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601150"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20343"},{"key":"R31","unstructured":"Maunsell E, Brisson J, Deschenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36:315,1993-320,"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1053\/clon.2000.9204"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4741.2003.09114.x"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.07.4062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:53:54Z","timestamp":1683831234000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.07.4062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,20]]},"references-count":33,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2007,8,20]]}},"alternative-id":["10.1200\/JCO.2006.07.4062"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.07.4062","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,20]]}}}